SlideShare a Scribd company logo
1 of 40
Chapter 6 
Life Span: Children 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Question 
• The book defines the pediatric patient as 
– A. Less than 12 years of age and under 30 kg 
– B. Less than 14 years of age and under 40 kg 
– C. Less than 16 years of age and under 50 kg 
– D. Less than 18 years of age and under 60 kg
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Answer 
• C. Less than 16 years of age and under 50 kg 
• Rationale: The book uses the age and weight cutoff 
of 16 years and 50 kg.
Pediatric Patient 
• When implementing pediatric drug therapy, the nurse 
must remember that children are different from adults in 
many ways. 
• Some drugs and administration routes are similar in 
adults and children. 
• The nursing management of drug therapy varies greatly. 
• Core patient variables differ from those in adult patients 
and from child to child because of the differences across 
the developmental stages of childhood. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pharmacotherapeutics 
• Therapeutic indications and effects for many drugs are 
similar for children and adults. 
• However, not all drugs that are labeled as safe for adults 
have been labeled as safe for children. 
• An estimated 75% of drugs regularly prescribed to 
children in the United States have never been labeled for 
use in any pediatric population. 
• It is now considered unethical to exclude children from 
drug studies. 
• Until all drugs have been tested and labeled for use in 
children, nurses need to be aware that off-label use will 
occur. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Calculation of Pediatric Drug Dosage 
• Even when a drug has the same labeled therapeutic uses 
in adults and children, a major difference is the 
appropriate drug dosage for different age groups. 
• Almost all pediatric drug dosages are based on the 
weight of the child in kilograms. 
• When a child dose is not specified, it can be determined 
from the adult dose based on the body surface area of 
the child. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nomogram 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Question 
• Calculate the correct dosage of the following drug: A 
child weighs 20 kilograms; the PDR states that the 
pediatric dosage for 30 mg/kg/day is 
– A. 200 mg/day 
– B. 300 mg/day 
– C. 600 mg/day 
– D. 800 mg/day
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Answer 
• C. 600 mg/day 
• Rationale: 20 kg x 30 mg/kg/day = 600 mg/day
Pharmacodynamics 
• A drug’s mechanism of action is the same in all 
individuals at all ages. 
• What distinguishes individual responses is the ability of 
the organ systems to function fully and appropriately. 
• In very young children, immature organ systems have 
less than optimal functioning. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pharmacokinetics 
• A child’s age, growth, and maturation can affect how the 
body absorbs, distributes, metabolizes, and excretes a 
drug. 
• The nurse can help maximize the therapeutic effects of a 
drug and minimize adverse effects. 
• Dosages must often be lowered to account for immature 
or impaired body systems in neonates and infants. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Absorption 
• In the pediatric patient, age, disease process, dosage 
form, route of administration, and foods and drugs 
present in the child’s body have an effect on drug 
absorption. 
• The infant’s GI tract is less acidic and thus has a higher 
pH than that of an adult. 
• As the GI tract matures, the gastric pH decreases and the 
GI tract becomes more acidic, reaching adult values at 
approximately 1 year of age. 
• Route of administration also affects absorption. 
• Compared with adults, infants and children have a 
greater body surface area. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Distribution 
• In a pediatric patient, drug distribution processes can 
differ from those in an adult. 
• Differences in body water and fat 
– Compared with adults, children have a higher 
concentration of water in their bodies and a lower 
concentration of fat. 
• Immature liver function 
– The neonate’s immature liver produces fewer plasma 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
proteins. 
• Immature blood–brain barrier 
– At birth, the blood–brain barrier is not fully 
developed.
Metabolism 
• The immaturity of the neonatal and infant liver results in 
decreased or incomplete metabolism of many drugs. 
• A child with an immature liver or compromised liver 
function is at risk for drug toxicity. 
• Drugs requiring oxidation for metabolism are frequently 
more rapidly metabolized in children than in adults 
because children have a faster resting respiratory rate. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Excretion 
• In children with impaired renal function, drug dosages 
should be altered to achieve and maintain therapeutic 
drug levels. 
• The neonate, especially the preterm infant, has immature 
kidneys, and renal excretion of drugs is slow. 
• A few drugs are excreted through the biliary tree into the 
intestinal tract. 
• Biliary blood flow is decreased during the first few days of 
life.
Contraindications and Precautions 
• Most drugs prescribed to children are prescribed off-label. 
• Off-label usage therefore requires cautious administration 
and careful, frequent assessments of the child. 
• Some drugs are known to be dangerous in children and 
are labeled as such. 
• The core drug knowledge must be determined for each 
drug before the drug can be administered to a child. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Adverse Effects and Drug Interactions 
• Adverse effects of some drugs are more severe and are 
more likely to occur in children because of the immature 
body systems of children. 
• Newborns and young children may experience serious 
adverse effects either from direct administration of a 
drug or through their mother’s use of a medication. 
• Other adverse effects on body systems occur only at 
specific phases of development. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Health Status 
• A child’s disease process can affect absorption of drugs 
from the GI tract. 
• Diarrhea, for example, decreases intestinal transit time 
and therefore decreases the time available for drug 
absorption. 
• Children with hepatic or renal disease cannot metabolize 
or excrete drugs as easily as other children. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Question 
• Constipation decreases drug absorption. 
– A. True 
– B. False
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Answer 
• B. False 
• Rationale: Constipation slows down the motility in the 
GI tract, thereby allowing more of the drug to be 
absorbed.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Life Span 
• Always consider the developmental stage of the pediatric 
patient. 
• In planning appropriate drug administration methods, 
explain the treatment and enlist the child’s cooperation. 
• Developmental considerations are especially important 
when communicating with the child.
Infants (Birth to 12 Months) 
• Some infants with a well-developed sucking reflex may 
willingly swallow a pleasant-tasting liquid drug through a 
bottle nipple. 
• Drugs in rectal suppository form may be given to infants 
if necessary. 
• If the IM route must be used, choose the smallest gauge 
of needle appropriate for the drug. 
• The preferred injection site for infants and children up to 
age 3 years is the vastus lateralis. 
• Drugs may be administered intravenously to the infant 
through a peripheral site. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Toddlers (13 Months to 3 Years) 
• Toddlers can swallow liquid forms of drugs, and older 
toddlers can chew oral drugs. 
• Because toddlers experience anxiety when separated 
from their parents, having a parent nearby usually helps 
the child’s cooperation during drug therapy. 
• Toddlers are also likely to be anxious or uncooperative 
during administration of rectal suppositories because of 
their experiences with toilet training and sphincter 
control. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Toddlers (13 Months to 3 Years) (cont.) 
• The vastus lateralis and rectus femoris remain the IM 
injection sites of choice for toddlers. 
• When IV drug therapy is necessary for toddlers, the scalp 
veins are still appropriate and can be used up to age 18 
months. 
• Although the scalp provides excellent IV access, it is not 
the first choice because of the anxiety it causes parents. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Preschoolers (3 to 5 Years) 
• Preschoolers are often uncooperative during drug 
administration. 
• Strategies for enlisting cooperation include offering 
choices. 
• When an IM injection must be given, the use of topical 
anesthetic creams to numb the site reduces pain. 
• Several sites may be used for IM injections in 
preschoolers, most commonly the vastus lateralis, rectus 
femoris, and ventrogluteal sites. 
• When IV drug therapy is necessary, peripheral sites are 
selected for the preschooler. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
School-Aged Children (6 to 12 Years) 
• The school-aged child is often very cooperative. 
• As with the preschooler, offer choices to help the school-aged 
patient exercise control. 
• The school-aged child takes pride in accomplishments, 
such as receiving an injection without incident. 
• Oral drugs may still be provided in liquid form or 
chewable tablets. Many school-aged children can also 
swallow pills. 
• The ventrogluteal site is recommended for an IM injection 
in the school-aged child. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Adolescents (13 to 16 Years) 
• Offer adolescents control whenever possible and let them 
make choices. 
• Adolescents are particularly sensitive about their bodies 
and their independence. 
• Routes of administration are similar to those for adults. 
– Oral forms of drug therapy include tablets or pills. 
– Suppositories can be used, but the adolescent is 
likely to be embarrassed. 
– IM injection sites are usually the same as for adults 
unless the adolescent is particularly small. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Lifestyle, Diet, and Habits 
• The infant’s primary food intake is milk and formula. 
These substances decrease acidity and thus increase 
gastric pH. 
• In school-aged children and adolescents, assess for the 
use and abuse of substances such as caffeine, alcohol, 
tobacco, and street drugs. 
• Adolescence is a time of experimentation, which may 
include experimentation with legal and illegal substances. 
• Question the parent regarding the use of herbal therapy. 
• Also consider the economic circumstances of the patient 
and the family. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Environment 
• Children may receive drug therapy in any setting. 
• Children receiving drug therapy at home need to have a 
parent or guardian responsible for ensuring that the child 
receives the prescribed therapy. 
• Does the home have electricity, a refrigerator, and indoor 
plumbing? 
• An important additional question to ask of the parent or 
caretaker is whether the home has a safe place to store 
prescription and nonprescription drugs away from 
children. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Culture and Inherited Traits 
• The family’s beliefs greatly affect a child’s attitude and 
adherence to the therapeutic regimen. 
• The child’s cultural background and heritage must be 
considered quite seriously when planning drug therapy. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Diagnoses and Outcomes 
• Nursing diagnoses and outcomes related to specific drug 
therapy for children are much the same as they are for 
adults. 
• Delayed Growth and Development 
– Desired outcome: The patient will achieve normal 
growth and development during drug therapy. 
• Ineffective Family Therapeutic Regimen Management 
– Desired outcome: Family members will master 
effective management strategies of the patient’s drug 
regimen. 
• Caregiver Role Strain 
– Desired outcome: The patient and family will develop 
effective coping skills to avoid, reduce, or relieve stress 
on family caregivers. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Maximizing Therapeutic Effects 
• Administering drugs safely and effectively to children 
requires an understanding of 
– Pediatric anatomy and physiology 
– Developmental and cognitive levels 
– The diagnosis and prognosis 
• Oral drug therapy 
– Although usually not painful, administration of oral 
medications can be traumatic. 
– Work carefully with the child to ensure that all of the 
drug is taken. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Maximizing Therapeutic Effects (cont.) 
• Parenteral drug therapy 
– To ensure accurate parenteral drug delivery, choose 
age-appropriate equipment. 
• Rectal drug therapy 
– Always give the patient and family a full explanation 
of the need to administer a drug rectally. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Preventing Medication Errors 
• Errors most likely to occur in the following situations: 
– Younger than 2 years old 
– In intensive care units 
– In Emergency Departments 
– Children who are receiving chemotherapy 
– Children who are receiving IV medication 
– Children whose weight was not documented 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Preventing Medication Errors (cont.) 
• Most of the problems in dosage calculation are related to 
the following: 
– Inability to identify the correct mathematical 
calculation 
– Poor math skills related to using fractions, 
percentages, decimals, and ratios 
– Infrequent use of calculation formulas 
– Inexperience in applying dosage calculation formulas 
to actual clinical practice 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Preventing Medication Errors (cont.) 
• Strategies for preventing medication errors: 
– Always weigh the child before administering any 
medication. 
– Standardize as much as possible. 
– Use computerized drug order entry systems. 
– Use reliable drug information sources. 
– Double-check each calculated dose for accuracy. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Preventing Medication Errors (cont.) 
• Strategies for preventing medication errors (cont.): 
– Measure and deliver oral medications via oral 
syringes only. 
– Involve the family in drug administration. 
– Communicate the drug therapy plan clearly when 
different nurses will be caring for the patient. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Reducing Psychological Stress and 
Anxiety 
• Some adverse effects in pediatric drug therapy involve 
psychological distress of the child or parent. 
• Consider age-related emotional needs when selecting 
appropriate communication techniques. 
• For school-aged children and adolescents, address feelings and 
discuss and answer questions as simply and honestly as 
possible. 
• Play therapy is useful for reducing a child’s anxiety and 
promoting understanding of drug therapy. 
• For preschoolers and school-aged children, take care to explore 
the child’s experiences with the health care system. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Providing Patient and Family Education 
• A crucial step in administering pediatric drug therapy is 
education. 
• Provide honest and detailed explanations and rationales. 
• Education for infant patients is directed solely toward the 
parent. 
• For toddlers, fully explain the rationale for drug therapy and 
the type of administration in private, away from the toddler. 
• Preschoolers require simple explanations. 
• The school-aged child can understand somewhat more in-depth 
explanations and will ask questions regarding drug 
therapy. 
• Adolescents are treated like adults with regard to full 
explanations and rationale for drug therapy. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Ongoing Assessment and Evaluation 
• Nursing management of drug therapy in children is 
considered effective when the developmental needs of 
the patient have been met. 
• Children who are receiving drug therapy for chronic 
conditions need to be reassessed frequently. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins

More Related Content

What's hot

Ppt chapter 04
Ppt chapter 04Ppt chapter 04
Ppt chapter 04stanbridge
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20stanbridge
 
Ppt chapter 28
Ppt chapter 28Ppt chapter 28
Ppt chapter 28stanbridge
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37stanbridge
 
Ppt chapter 23
Ppt chapter 23Ppt chapter 23
Ppt chapter 23stanbridge
 
Ppt chapter 13
Ppt chapter 13Ppt chapter 13
Ppt chapter 13stanbridge
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41stanbridge
 
Ppt chapter 14
Ppt chapter 14Ppt chapter 14
Ppt chapter 14stanbridge
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40stanbridge
 
Ppt chapter 05
Ppt chapter 05Ppt chapter 05
Ppt chapter 05stanbridge
 
Ppt chapter 45
Ppt chapter 45Ppt chapter 45
Ppt chapter 45stanbridge
 
Ppt chapter 12
Ppt chapter 12Ppt chapter 12
Ppt chapter 12stanbridge
 
Ppt chapter 01
Ppt chapter 01Ppt chapter 01
Ppt chapter 01stanbridge
 
CARE OF PAEDIATRIC, GERIATRIC, PREGNANT AND LACTATING
CARE OF PAEDIATRIC, GERIATRIC, PREGNANT AND LACTATING CARE OF PAEDIATRIC, GERIATRIC, PREGNANT AND LACTATING
CARE OF PAEDIATRIC, GERIATRIC, PREGNANT AND LACTATING Ramesh Ganpisetti
 
Reducing the risk of medication alcohol interactions in older adults march 2015
Reducing the risk of medication alcohol interactions in older adults march  2015Reducing the risk of medication alcohol interactions in older adults march  2015
Reducing the risk of medication alcohol interactions in older adults march 2015nicowef
 
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 General prescribing guidelines for Pediatrics geriatrics pregnancy lactating... General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...Koppala RVS Chaitanya
 
Clinical trial in special population final
Clinical trial in special population finalClinical trial in special population final
Clinical trial in special population finalanupam raghunath
 
General prescribing guidelines for pediatrics, geriatrics and pregnancy
General prescribing guidelines for pediatrics, geriatrics and pregnancyGeneral prescribing guidelines for pediatrics, geriatrics and pregnancy
General prescribing guidelines for pediatrics, geriatrics and pregnancyDr. Ankit Gaur
 
Pediatric pharmacology by dr.azad al.kurdi
Pediatric pharmacology by dr.azad al.kurdiPediatric pharmacology by dr.azad al.kurdi
Pediatric pharmacology by dr.azad al.kurdiAzad Haleem
 
Safe drug use main wala
Safe drug use main walaSafe drug use main wala
Safe drug use main walaranishetty
 

What's hot (20)

Ppt chapter 04
Ppt chapter 04Ppt chapter 04
Ppt chapter 04
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20
 
Ppt chapter 28
Ppt chapter 28Ppt chapter 28
Ppt chapter 28
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
 
Ppt chapter 23
Ppt chapter 23Ppt chapter 23
Ppt chapter 23
 
Ppt chapter 13
Ppt chapter 13Ppt chapter 13
Ppt chapter 13
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
 
Ppt chapter 14
Ppt chapter 14Ppt chapter 14
Ppt chapter 14
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40
 
Ppt chapter 05
Ppt chapter 05Ppt chapter 05
Ppt chapter 05
 
Ppt chapter 45
Ppt chapter 45Ppt chapter 45
Ppt chapter 45
 
Ppt chapter 12
Ppt chapter 12Ppt chapter 12
Ppt chapter 12
 
Ppt chapter 01
Ppt chapter 01Ppt chapter 01
Ppt chapter 01
 
CARE OF PAEDIATRIC, GERIATRIC, PREGNANT AND LACTATING
CARE OF PAEDIATRIC, GERIATRIC, PREGNANT AND LACTATING CARE OF PAEDIATRIC, GERIATRIC, PREGNANT AND LACTATING
CARE OF PAEDIATRIC, GERIATRIC, PREGNANT AND LACTATING
 
Reducing the risk of medication alcohol interactions in older adults march 2015
Reducing the risk of medication alcohol interactions in older adults march  2015Reducing the risk of medication alcohol interactions in older adults march  2015
Reducing the risk of medication alcohol interactions in older adults march 2015
 
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 General prescribing guidelines for Pediatrics geriatrics pregnancy lactating... General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 
Clinical trial in special population final
Clinical trial in special population finalClinical trial in special population final
Clinical trial in special population final
 
General prescribing guidelines for pediatrics, geriatrics and pregnancy
General prescribing guidelines for pediatrics, geriatrics and pregnancyGeneral prescribing guidelines for pediatrics, geriatrics and pregnancy
General prescribing guidelines for pediatrics, geriatrics and pregnancy
 
Pediatric pharmacology by dr.azad al.kurdi
Pediatric pharmacology by dr.azad al.kurdiPediatric pharmacology by dr.azad al.kurdi
Pediatric pharmacology by dr.azad al.kurdi
 
Safe drug use main wala
Safe drug use main walaSafe drug use main wala
Safe drug use main wala
 

Viewers also liked

Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38stanbridge
 
Ppt chapter 39
Ppt chapter 39Ppt chapter 39
Ppt chapter 39stanbridge
 
Nur 3042 chapter002
Nur 3042 chapter002Nur 3042 chapter002
Nur 3042 chapter002stanbridge
 
Ppt chapter 03
Ppt chapter 03Ppt chapter 03
Ppt chapter 03stanbridge
 
Ppt chapter 34-1
Ppt chapter 34-1Ppt chapter 34-1
Ppt chapter 34-1stanbridge
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41stanbridge
 
Ppt chapter 45
Ppt chapter 45Ppt chapter 45
Ppt chapter 45stanbridge
 
Ppt chapter 17
Ppt chapter 17Ppt chapter 17
Ppt chapter 17stanbridge
 
Chapter 20 ppt
Chapter 20 pptChapter 20 ppt
Chapter 20 pptstanbridge
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16stanbridge
 
Ppt chapter 50
Ppt chapter 50Ppt chapter 50
Ppt chapter 50stanbridge
 
Ppt chapter 29
Ppt chapter 29Ppt chapter 29
Ppt chapter 29stanbridge
 
Occupational Therapy in the Community
Occupational Therapy in the CommunityOccupational Therapy in the Community
Occupational Therapy in the Communitystanbridge
 

Viewers also liked (18)

Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38
 
Ppt chapter 39
Ppt chapter 39Ppt chapter 39
Ppt chapter 39
 
Chapter033
Chapter033Chapter033
Chapter033
 
Nur 3042 chapter002
Nur 3042 chapter002Nur 3042 chapter002
Nur 3042 chapter002
 
management and assessment of patient with hemaetologic desorder
management and assessment of patient with hemaetologic desordermanagement and assessment of patient with hemaetologic desorder
management and assessment of patient with hemaetologic desorder
 
Ppt chapter 03
Ppt chapter 03Ppt chapter 03
Ppt chapter 03
 
Chapter 007
Chapter 007Chapter 007
Chapter 007
 
Ppt chapter 34-1
Ppt chapter 34-1Ppt chapter 34-1
Ppt chapter 34-1
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
 
Ppt chapter 45
Ppt chapter 45Ppt chapter 45
Ppt chapter 45
 
Ppt chapter 17
Ppt chapter 17Ppt chapter 17
Ppt chapter 17
 
Chapter 20 ppt
Chapter 20 pptChapter 20 ppt
Chapter 20 ppt
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
 
Chapter 01
Chapter 01Chapter 01
Chapter 01
 
Ppt chapter 50
Ppt chapter 50Ppt chapter 50
Ppt chapter 50
 
Ppt chapter 29
Ppt chapter 29Ppt chapter 29
Ppt chapter 29
 
Chapter014
Chapter014Chapter014
Chapter014
 
Occupational Therapy in the Community
Occupational Therapy in the CommunityOccupational Therapy in the Community
Occupational Therapy in the Community
 

Similar to Ppt chapter 06

Chapter 16 ppt
Chapter 16 pptChapter 16 ppt
Chapter 16 pptstanbridge
 
Ppt chapter 53-1
Ppt chapter 53-1Ppt chapter 53-1
Ppt chapter 53-1stanbridge
 
Counseling on early childhood concerns
Counseling on early childhood concernsCounseling on early childhood concerns
Counseling on early childhood concernsbausher willayat
 
FDA 2013 Clinical Investigator Training Course: Clinical Discussion of Specia...
FDA 2013 Clinical Investigator Training Course: Clinical Discussion of Specia...FDA 2013 Clinical Investigator Training Course: Clinical Discussion of Specia...
FDA 2013 Clinical Investigator Training Course: Clinical Discussion of Specia...MedicReS
 
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptxGENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptxkavitharaninachiya
 
Paediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptxPaediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptx65NidheeshKumarPraba
 
Medicine Management
Medicine ManagementMedicine Management
Medicine ManagementJeff Nevil
 
Principles of pharmacotherapy in neonates and paediatric population21
Principles of pharmacotherapy in neonates and paediatric population21Principles of pharmacotherapy in neonates and paediatric population21
Principles of pharmacotherapy in neonates and paediatric population21DrSatyabrataSahoo
 
Ppt chapter 22
Ppt chapter 22Ppt chapter 22
Ppt chapter 22stanbridge
 
Pharm Absorption
Pharm AbsorptionPharm Absorption
Pharm Absorptionlkester83
 
Pharm Absorption
Pharm AbsorptionPharm Absorption
Pharm Absorptionlkester83
 
Paediatric drugs, its dose and dosage forms
Paediatric drugs, its dose and dosage formsPaediatric drugs, its dose and dosage forms
Paediatric drugs, its dose and dosage formsAiswarya Thomas
 
Nas treating pregnant_women_final
Nas treating pregnant_women_finalNas treating pregnant_women_final
Nas treating pregnant_women_finalOPUNITE
 
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...Varsha Shah
 

Similar to Ppt chapter 06 (20)

Chapter 16 ppt
Chapter 16 pptChapter 16 ppt
Chapter 16 ppt
 
Ppt chapter 53-1
Ppt chapter 53-1Ppt chapter 53-1
Ppt chapter 53-1
 
Counseling on early childhood concerns
Counseling on early childhood concernsCounseling on early childhood concerns
Counseling on early childhood concerns
 
FDA 2013 Clinical Investigator Training Course: Clinical Discussion of Specia...
FDA 2013 Clinical Investigator Training Course: Clinical Discussion of Specia...FDA 2013 Clinical Investigator Training Course: Clinical Discussion of Specia...
FDA 2013 Clinical Investigator Training Course: Clinical Discussion of Specia...
 
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptxGENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
 
Paediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptxPaediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptx
 
Paediatrics
PaediatricsPaediatrics
Paediatrics
 
Medicine Management
Medicine ManagementMedicine Management
Medicine Management
 
General Prescribing Guidelines.pptx
General Prescribing Guidelines.pptxGeneral Prescribing Guidelines.pptx
General Prescribing Guidelines.pptx
 
Principles of pharmacotherapy in neonates and paediatric population21
Principles of pharmacotherapy in neonates and paediatric population21Principles of pharmacotherapy in neonates and paediatric population21
Principles of pharmacotherapy in neonates and paediatric population21
 
Ppt chapter 22
Ppt chapter 22Ppt chapter 22
Ppt chapter 22
 
Pharm Absorption
Pharm AbsorptionPharm Absorption
Pharm Absorption
 
Pharm Absorption
Pharm AbsorptionPharm Absorption
Pharm Absorption
 
Paediatric drugs, its dose and dosage forms
Paediatric drugs, its dose and dosage formsPaediatric drugs, its dose and dosage forms
Paediatric drugs, its dose and dosage forms
 
Week 3 Health
Week 3 HealthWeek 3 Health
Week 3 Health
 
Nas treating pregnant_women_final
Nas treating pregnant_women_finalNas treating pregnant_women_final
Nas treating pregnant_women_final
 
Iycf revision class (1)
Iycf  revision class (1)Iycf  revision class (1)
Iycf revision class (1)
 
Iycf revision class (1)
Iycf  revision class (1)Iycf  revision class (1)
Iycf revision class (1)
 
Iycf revision class (1)
Iycf  revision class (1)Iycf  revision class (1)
Iycf revision class (1)
 
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
 

More from stanbridge

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecturestanbridge
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2stanbridge
 
Creating a poster
Creating a posterCreating a poster
Creating a posterstanbridge
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Disseminationstanbridge
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5stanbridge
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4stanbridge
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors stanbridge
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learnerstanbridge
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policystanbridge
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentstanbridge
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005stanbridge
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007stanbridge
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006stanbridge
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004stanbridge
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009stanbridge
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008stanbridge
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21stanbridge
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22stanbridge
 

More from stanbridge (20)

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecture
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2
 
Creating a poster
Creating a posterCreating a poster
Creating a poster
 
Sample poster
Sample posterSample poster
Sample poster
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Dissemination
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learner
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policy
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessment
 
Ot5101 week1
Ot5101 week1Ot5101 week1
Ot5101 week1
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22
 

Ppt chapter 06

  • 1. Chapter 6 Life Span: Children Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 2. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • The book defines the pediatric patient as – A. Less than 12 years of age and under 30 kg – B. Less than 14 years of age and under 40 kg – C. Less than 16 years of age and under 50 kg – D. Less than 18 years of age and under 60 kg
  • 3. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • C. Less than 16 years of age and under 50 kg • Rationale: The book uses the age and weight cutoff of 16 years and 50 kg.
  • 4. Pediatric Patient • When implementing pediatric drug therapy, the nurse must remember that children are different from adults in many ways. • Some drugs and administration routes are similar in adults and children. • The nursing management of drug therapy varies greatly. • Core patient variables differ from those in adult patients and from child to child because of the differences across the developmental stages of childhood. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 5. Pharmacotherapeutics • Therapeutic indications and effects for many drugs are similar for children and adults. • However, not all drugs that are labeled as safe for adults have been labeled as safe for children. • An estimated 75% of drugs regularly prescribed to children in the United States have never been labeled for use in any pediatric population. • It is now considered unethical to exclude children from drug studies. • Until all drugs have been tested and labeled for use in children, nurses need to be aware that off-label use will occur. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 6. Calculation of Pediatric Drug Dosage • Even when a drug has the same labeled therapeutic uses in adults and children, a major difference is the appropriate drug dosage for different age groups. • Almost all pediatric drug dosages are based on the weight of the child in kilograms. • When a child dose is not specified, it can be determined from the adult dose based on the body surface area of the child. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 7. Nomogram Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 8. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • Calculate the correct dosage of the following drug: A child weighs 20 kilograms; the PDR states that the pediatric dosage for 30 mg/kg/day is – A. 200 mg/day – B. 300 mg/day – C. 600 mg/day – D. 800 mg/day
  • 9. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • C. 600 mg/day • Rationale: 20 kg x 30 mg/kg/day = 600 mg/day
  • 10. Pharmacodynamics • A drug’s mechanism of action is the same in all individuals at all ages. • What distinguishes individual responses is the ability of the organ systems to function fully and appropriately. • In very young children, immature organ systems have less than optimal functioning. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 11. Pharmacokinetics • A child’s age, growth, and maturation can affect how the body absorbs, distributes, metabolizes, and excretes a drug. • The nurse can help maximize the therapeutic effects of a drug and minimize adverse effects. • Dosages must often be lowered to account for immature or impaired body systems in neonates and infants. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 12. Absorption • In the pediatric patient, age, disease process, dosage form, route of administration, and foods and drugs present in the child’s body have an effect on drug absorption. • The infant’s GI tract is less acidic and thus has a higher pH than that of an adult. • As the GI tract matures, the gastric pH decreases and the GI tract becomes more acidic, reaching adult values at approximately 1 year of age. • Route of administration also affects absorption. • Compared with adults, infants and children have a greater body surface area. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 13. Distribution • In a pediatric patient, drug distribution processes can differ from those in an adult. • Differences in body water and fat – Compared with adults, children have a higher concentration of water in their bodies and a lower concentration of fat. • Immature liver function – The neonate’s immature liver produces fewer plasma Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins proteins. • Immature blood–brain barrier – At birth, the blood–brain barrier is not fully developed.
  • 14. Metabolism • The immaturity of the neonatal and infant liver results in decreased or incomplete metabolism of many drugs. • A child with an immature liver or compromised liver function is at risk for drug toxicity. • Drugs requiring oxidation for metabolism are frequently more rapidly metabolized in children than in adults because children have a faster resting respiratory rate. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 15. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Excretion • In children with impaired renal function, drug dosages should be altered to achieve and maintain therapeutic drug levels. • The neonate, especially the preterm infant, has immature kidneys, and renal excretion of drugs is slow. • A few drugs are excreted through the biliary tree into the intestinal tract. • Biliary blood flow is decreased during the first few days of life.
  • 16. Contraindications and Precautions • Most drugs prescribed to children are prescribed off-label. • Off-label usage therefore requires cautious administration and careful, frequent assessments of the child. • Some drugs are known to be dangerous in children and are labeled as such. • The core drug knowledge must be determined for each drug before the drug can be administered to a child. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 17. Adverse Effects and Drug Interactions • Adverse effects of some drugs are more severe and are more likely to occur in children because of the immature body systems of children. • Newborns and young children may experience serious adverse effects either from direct administration of a drug or through their mother’s use of a medication. • Other adverse effects on body systems occur only at specific phases of development. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 18. Health Status • A child’s disease process can affect absorption of drugs from the GI tract. • Diarrhea, for example, decreases intestinal transit time and therefore decreases the time available for drug absorption. • Children with hepatic or renal disease cannot metabolize or excrete drugs as easily as other children. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 19. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • Constipation decreases drug absorption. – A. True – B. False
  • 20. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • B. False • Rationale: Constipation slows down the motility in the GI tract, thereby allowing more of the drug to be absorbed.
  • 21. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Life Span • Always consider the developmental stage of the pediatric patient. • In planning appropriate drug administration methods, explain the treatment and enlist the child’s cooperation. • Developmental considerations are especially important when communicating with the child.
  • 22. Infants (Birth to 12 Months) • Some infants with a well-developed sucking reflex may willingly swallow a pleasant-tasting liquid drug through a bottle nipple. • Drugs in rectal suppository form may be given to infants if necessary. • If the IM route must be used, choose the smallest gauge of needle appropriate for the drug. • The preferred injection site for infants and children up to age 3 years is the vastus lateralis. • Drugs may be administered intravenously to the infant through a peripheral site. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 23. Toddlers (13 Months to 3 Years) • Toddlers can swallow liquid forms of drugs, and older toddlers can chew oral drugs. • Because toddlers experience anxiety when separated from their parents, having a parent nearby usually helps the child’s cooperation during drug therapy. • Toddlers are also likely to be anxious or uncooperative during administration of rectal suppositories because of their experiences with toilet training and sphincter control. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 24. Toddlers (13 Months to 3 Years) (cont.) • The vastus lateralis and rectus femoris remain the IM injection sites of choice for toddlers. • When IV drug therapy is necessary for toddlers, the scalp veins are still appropriate and can be used up to age 18 months. • Although the scalp provides excellent IV access, it is not the first choice because of the anxiety it causes parents. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 25. Preschoolers (3 to 5 Years) • Preschoolers are often uncooperative during drug administration. • Strategies for enlisting cooperation include offering choices. • When an IM injection must be given, the use of topical anesthetic creams to numb the site reduces pain. • Several sites may be used for IM injections in preschoolers, most commonly the vastus lateralis, rectus femoris, and ventrogluteal sites. • When IV drug therapy is necessary, peripheral sites are selected for the preschooler. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 26. School-Aged Children (6 to 12 Years) • The school-aged child is often very cooperative. • As with the preschooler, offer choices to help the school-aged patient exercise control. • The school-aged child takes pride in accomplishments, such as receiving an injection without incident. • Oral drugs may still be provided in liquid form or chewable tablets. Many school-aged children can also swallow pills. • The ventrogluteal site is recommended for an IM injection in the school-aged child. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 27. Adolescents (13 to 16 Years) • Offer adolescents control whenever possible and let them make choices. • Adolescents are particularly sensitive about their bodies and their independence. • Routes of administration are similar to those for adults. – Oral forms of drug therapy include tablets or pills. – Suppositories can be used, but the adolescent is likely to be embarrassed. – IM injection sites are usually the same as for adults unless the adolescent is particularly small. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 28. Lifestyle, Diet, and Habits • The infant’s primary food intake is milk and formula. These substances decrease acidity and thus increase gastric pH. • In school-aged children and adolescents, assess for the use and abuse of substances such as caffeine, alcohol, tobacco, and street drugs. • Adolescence is a time of experimentation, which may include experimentation with legal and illegal substances. • Question the parent regarding the use of herbal therapy. • Also consider the economic circumstances of the patient and the family. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 29. Environment • Children may receive drug therapy in any setting. • Children receiving drug therapy at home need to have a parent or guardian responsible for ensuring that the child receives the prescribed therapy. • Does the home have electricity, a refrigerator, and indoor plumbing? • An important additional question to ask of the parent or caretaker is whether the home has a safe place to store prescription and nonprescription drugs away from children. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 30. Culture and Inherited Traits • The family’s beliefs greatly affect a child’s attitude and adherence to the therapeutic regimen. • The child’s cultural background and heritage must be considered quite seriously when planning drug therapy. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 31. Nursing Diagnoses and Outcomes • Nursing diagnoses and outcomes related to specific drug therapy for children are much the same as they are for adults. • Delayed Growth and Development – Desired outcome: The patient will achieve normal growth and development during drug therapy. • Ineffective Family Therapeutic Regimen Management – Desired outcome: Family members will master effective management strategies of the patient’s drug regimen. • Caregiver Role Strain – Desired outcome: The patient and family will develop effective coping skills to avoid, reduce, or relieve stress on family caregivers. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 32. Maximizing Therapeutic Effects • Administering drugs safely and effectively to children requires an understanding of – Pediatric anatomy and physiology – Developmental and cognitive levels – The diagnosis and prognosis • Oral drug therapy – Although usually not painful, administration of oral medications can be traumatic. – Work carefully with the child to ensure that all of the drug is taken. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 33. Maximizing Therapeutic Effects (cont.) • Parenteral drug therapy – To ensure accurate parenteral drug delivery, choose age-appropriate equipment. • Rectal drug therapy – Always give the patient and family a full explanation of the need to administer a drug rectally. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 34. Preventing Medication Errors • Errors most likely to occur in the following situations: – Younger than 2 years old – In intensive care units – In Emergency Departments – Children who are receiving chemotherapy – Children who are receiving IV medication – Children whose weight was not documented Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 35. Preventing Medication Errors (cont.) • Most of the problems in dosage calculation are related to the following: – Inability to identify the correct mathematical calculation – Poor math skills related to using fractions, percentages, decimals, and ratios – Infrequent use of calculation formulas – Inexperience in applying dosage calculation formulas to actual clinical practice Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 36. Preventing Medication Errors (cont.) • Strategies for preventing medication errors: – Always weigh the child before administering any medication. – Standardize as much as possible. – Use computerized drug order entry systems. – Use reliable drug information sources. – Double-check each calculated dose for accuracy. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 37. Preventing Medication Errors (cont.) • Strategies for preventing medication errors (cont.): – Measure and deliver oral medications via oral syringes only. – Involve the family in drug administration. – Communicate the drug therapy plan clearly when different nurses will be caring for the patient. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 38. Reducing Psychological Stress and Anxiety • Some adverse effects in pediatric drug therapy involve psychological distress of the child or parent. • Consider age-related emotional needs when selecting appropriate communication techniques. • For school-aged children and adolescents, address feelings and discuss and answer questions as simply and honestly as possible. • Play therapy is useful for reducing a child’s anxiety and promoting understanding of drug therapy. • For preschoolers and school-aged children, take care to explore the child’s experiences with the health care system. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 39. Providing Patient and Family Education • A crucial step in administering pediatric drug therapy is education. • Provide honest and detailed explanations and rationales. • Education for infant patients is directed solely toward the parent. • For toddlers, fully explain the rationale for drug therapy and the type of administration in private, away from the toddler. • Preschoolers require simple explanations. • The school-aged child can understand somewhat more in-depth explanations and will ask questions regarding drug therapy. • Adolescents are treated like adults with regard to full explanations and rationale for drug therapy. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 40. Ongoing Assessment and Evaluation • Nursing management of drug therapy in children is considered effective when the developmental needs of the patient have been met. • Children who are receiving drug therapy for chronic conditions need to be reassessed frequently. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins